Slower Decline in Lung Function With Anthocyanin Intake

This article originally appeared here.
Share this content:
Slower Decline in Lung Function With Anthocyanin Intake
Slower Decline in Lung Function With Anthocyanin Intake

MONDAY, May 21, 2018 (HealthDay News) -- Anthocyanin intake is associated with slower decline in lung function, according to a study presented at the American Thoracic Society's 2018 International Conference, held from May 18 to 23 in San Diego.

Vanessa Garcia-Larsen, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues examined the correlation between dietary intake of anthocyanin and lung function decline in 463 adults from two cohorts from England and Norway. The effect of anthocyanin intake was examined on forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the ratio of FEV1/FVC.

The researchers found that the adjusted mean annual change was −18.9 mL/year and −22.2 mL/year for FEV1 and FVC, respectively, for individuals with the lowest quartile of anthocyanin intake. Slower annual rates of decline were seen in FEV1 and FVC for participants with the highest quartile of anthocyanin intake (−9.8 mL/year for both). The FEV1/FVC ratio decline was also slower for the highest versus the lowest quartile of anthocyanin intake (−0.02/year). In association with increased anthocyanin intake, significantly slower rates of decline in the FEV1/FVC ratio were seen for never smokers and those who had quit.

"Our study suggests that the general population could benefit from consuming more fruits rich in these flavonoids like berries, particularly those who have given up smoking or have never smoked," Garcia-Larsen said in a statement.

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »